Anaconda Biomed Secures 15 Million Euro in Series A Financing Led by Ysios Capital, Innogest Capital and Omega Funds

by Ysios Capital

Anaconda Biomed Secures 15 Million Euro in Series A Financing Led by Ysios Capital, Innogest Capital and Omega Funds

Read more

BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital

by Ysios Capital

BioClin Therapeutics, Inc., a privately-­‐held clinical stage drug development company developing a first-­‐in-­‐class anti-­‐FGFR3 (fibroblast growth factor receptor 3) monoclonal antibod...

Read more

Prexton Therapeutics - participated by Ysios Capital - Series B financing round raises € 29 millions to advance its novel Parkinson’s therapeutic

by Ysios Capital

Forbion Capital Partners (NL) and Seroba Life Sciences (IE) co-led the financing round, which includes current investors Merck Ventures (NL), Ysios Capital (ES) and Sunstone Capital (DK). Marco Boorsm...

Read more

TiGenix, participated by Ysios Capital, announces launch of proposed initial public offering in the United States

by Ysios Capital

TiGenix has announced that it intends to offer and sell, subject to market and other conditions, 2.75 million American Depositary Shares representing 55 million ordinary shares in an initial public o...

Read more

OxThera raises EUR 32 million to complete development of Oxabact® for treatment of Primary hyperoxaluria

by Ysios Capital

The investment round is co-led by Life Sciences Partners, Netherlands, Ysios Capital, Spain, Sunstone Capital, Denmark, and Flerie Invest, Sweden, in addition to current shareholders Kurma Partners, F...

Read more

CorWave Raises $17.1 Million in Series B Financing

by Ysios Capital

Existing shareholders including Sofinnova Partners, Bpifrance and Seventure were joined by two new investors: Novo Seeds, which led the round, and Ysios Capital

Read more

Ysios Capital cierra su segundo fondo, Ysios BioFund II Innvierte, con un importe total de 126M EUR

by Ysios Capital

Ysios BioFund II Innvierte cuenta con una sólida base de inversores entre los que se encuentran: CDTI a través de su programa Innvierte, Fondo Europeo de Inversiones a través de InnovFin SME Ventur...

Read more

Aura Biosciences secures $8 million in additional funding and augments Board of Directors and Clinical Advisory Board

by Ysios Capital

The round of financing consisted of expanded funding commitments from its existing investors: Advent Partners, Chiesi Ventures, Ysios Capital, Alexandria Venture Investments and several individual inv...

Read more

CVRx® Secures $113 Million in New Financing

by Ysios Capital

CVRx, Inc., a private medical device company, has secured equity financing totaling $93 million and a new $20 million debt facility. CVRx plans to use the proceeds for the primary purposes of completi...

Read more

Los fondos de capital catalanes captan 1.100 millones para invertir en empresas

by La Vanguardia

Las grandes gestoras de fondos de capital con sede en Barcelona confían en captar este año alrededor de 1.100 millones de euros para invertir en empresas. Esa es la cantidad con la que ya cuentan en...

Read more

Ysios Capital Partners takes part in Kala Pharmaceuticals' closing of $68 Million Series C Financing

by Ysios Capital

Kala was founded by leaders in the fields of nanomedicine and biopharmaceutical engineering, and is backed by leading life sciences investors including Longitude Capital, OrbiMed, Vivo Capital, CAM Ca...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Bullnet Capital leads Investment round i...

by Bullnet Capital

Bullnet Capital has led an investment round in Mapsi Photonics, dedica...

Photos Stream